Null or Nil

Null or Nil Steve Bunk's 5-PRIME on the null hypothesis was a good, brief piece.1 However, he made the common error of confusing the null hypothesis (the hypothesis against which the research result is tested) with the nil hypothesis (definition: if samples come from populations with identical parameters, the hypothesized difference is zero). The null hypothesis--that is, the one "sought to be nullified"--may be nil. But it also may be a population parameter, or a specified difference betwe

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Steve Bunk's 5-PRIME on the null hypothesis was a good, brief piece.1 However, he made the common error of confusing the null hypothesis (the hypothesis against which the research result is tested) with the nil hypothesis (definition: if samples come from populations with identical parameters, the hypothesized difference is zero). The null hypothesis--that is, the one "sought to be nullified"--may be nil. But it also may be a population parameter, or a specified difference between population parameters, against which any difference between the samples are to be tested.

Statistical significance is a function of sample size. With large enough samples, practically every difference will be statistically significant; with small samples, important results may be overlooked if statistical significance is relied on exclusively. Bunk's reminder that statistical significance does not necessarily indicate substantive significance is, for a few reasons, on target.

James P. Shaver
Hyrum, UT
shaver@cc.usu.edu

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies